Noosa News
There is a problem with AstraZeneca … but it’s not clotting
It’s not about the risk of clotting, which everyone agrees is very rare, it’s about effectiveness. From the start, the AstraZeneca vaccine has performed poorly when compared against the mRNA vaccines, such as Pfizer and Moderna. In later trials, when jabs were spaced out to 12 weeks apart,…
Click here to view the original article.
Continue Reading
-
General13 hours agoIvan Cleary says Panthers trainer Corey Bocking ‘struggling’ after receiving five-match suspension
-
General23 hours agoFlash floods in India wash away village, kill four and leave over 50 missing
-
General22 hours agoIsrael’s war in Gaza faces difficult path forward after release of hostage videos
-
General18 hours agoConcerns about sewage discharge in Sydney’s drinking water catchment